<DOC>
	<DOCNO>NCT00232596</DOCNO>
	<brief_summary>This Phase 3 study conduct evaluate efficacy safety retigabine dosed 1200 mg/day , three equally divided dos , compare placebo patient epilepsy receive three establish antiepileptic drug ( AEDs ) .</brief_summary>
	<brief_title>Retigabine ( Adjunctive Therapy ) Efficacy Safety Study Partial Onset Refractory Seizures Epilepsy</brief_title>
	<detailed_description>This Phase 3 study conduct North America , Argentina , Brazil evaluate efficacy safety retigabine dosed 1200 mg/day , three equally divided dos , compare placebo patient epilepsy receive three establish antiepileptic drug ( AEDs ) . The primary objective demonstrate superior change total partial seizure frequency four week baseline double-blind period . The proportion responder ( great equal 50 % reduction total partial seizure frequency four week baseline double-blind period ) also evaluate .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Ezogabine</mesh_term>
	<criteria>Diagnosis refractory epilepsy simple complex partial onset seizure without secondary generalization 28day partial seizure frequency rate four partial seizure 8week baseline phase Currently treat three establish AEDs Vagal Nerve Stimulator may include Existing medical psychiatric condition could affect patient 's health compromise ability participate study Clinically significant abnormality physical exam , vital sign , ECG , liver function test Impaired renal function ( creatinine clearance le 50 mL/minute ) Evidence progressive central nervous disease , lesion , encephalopathy History primary generalize seizure History cluster flurry status epilepticus within 12 month study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Partial Seizures</keyword>
	<keyword>Anticonvulsant</keyword>
	<keyword>Complex Partial Seizures</keyword>
	<keyword>Potassium Channels</keyword>
	<keyword>Epilepsy</keyword>
</DOC>